Pharmacists Bulletin Index
Following is a list of Medicaid General and Special Bulletin articles (2000-present) that pertain specifically to Pharmacists (Outpatient Pharmacy Program).
For a complete list of articles for all providers (including articles about National Provider Identifier) refer to the Index of All Medicaid Bulletins.
- 34-Day Grace Period for Prescription Drug PA, 7/02
- A+Kids Medicaid and Health Choice –
Unlimited Overrides End on
March 15, 2012
- Access to Over-the-Counter Medications Covered by N.C. Medicaid, 11/05
- Addition of Dispense As Written Code "8", 6/09
- Addition of Pen Needles to Pharmacy Point of Sale, 3/10
- Additional Information on Prodigy Diabetic Supplies:
- Additions to Over-the-Counter Medications Coverage List, 1/08
- Administrative Update for Synagis Claims Processing, 2/06
- Automatic Refills and Automatic Shipments
No longer Allowed, 1/12
- Benzodiazepines and Barbiturates are No Longer Covered for Dual Eligible Beneficiaries, 12/12, 1/13
- Billing for MiraLax, 6/07
- Billing Outpatient Pharmacy Claims for Recipients with Retroactive Medicaid, 2/08
- Botox Online Billing Restriction Removed, 4/07
- Calling the Prescriber on a Non-Compliant Prescription, 5/08
- Change in the Determination of the Prescription Count for Global Limits, the FORM and Recipient Opt-In Programs, 1/08
- Changes in Drug Rebate Manufacturers:
- Changes to HCPCS Codes A4253, A4259, and S8490, 7/10
- Changes to Prior Authorization Requirements for Antinarcolepsy/Antihyperkinesis Agents, 9/09
- Cialis, 2/04
- Clarification on Coverage of Birth Control Pills for Diagnosis Other than Contraception, 4/06
- CMS Process to Ensure Effective Transition to Medicare Part D Prescription Drug Coverage, 2/06
- Correction for Removal of Smoking Cessation Medications, 2/05
- Coverage of Over-the-Counter Medications, 12/03
- Coverage of Over-the-Counter Second Generation Antihistamine and Decongestant Combinations, 9/10
- Coverage of Prescription Vitamins and Mineral Products for N.C. Medicaid Recipient, 4/11
- Days Supply for Prescriptions with "Use as Directed" Instructions, 3/08
- Days Supply on Pharmacy Claims:
- Delay in Non-Enrolled Prescriber Edit, 3/13
- Denial on Medicaid Covered Excluded Drugs, 2/06
- Devices Are Not Covered in the Outpatient Pharmacy Program, 9/07
- Discontinuation of Coverage for Anorexia, Weight, Loss, and Weight Gain Products and Medications, 11/04
- Discontinuation of Coverage for Vioxx, 11/04
- Discontinuation of the 34-Day Grace Period for Prescription Drug PA for Long Term Care Facilities, 12/05
- Discontinuation of Focused Risk Management Program, 12/10
- Drug Coverage under Hospice, 7/05
- Drug Utilization Review Early Refill Alert, 12/09
- Drug Utilization Review Intervention Letters, 3/11
- Emergency Fills for Recipients in the Focused Risk Management Program, 2/09
- Emergency Supplies of Medications under Focused Risk Management, 9/07
- End-Dated Coverage for Exocrine Pancreatic Insufficiency Drugs, 6/10
- End-Dated Coverage of Generic Colchicine, 12/10
- Enhanced Specialty Drug Discount Reimbursement Inquiries, 11/08
- Expansion in Coverage of Zelnorm, 3/05
- Family Planning Waiver Provider Seminar, 4/06
- Focused Risk Management Program Quarterly Letter Update, 4/08
- Focused Risk Management Program Reviews and Submission of Fees, 11/08
- Hemophilia Specialty Pharmacy Program, 1/13
- Inaccurate Billing of Pharmacy Claims, 11/05
- Insulin Syringes, 7/09
- Joint Statement from the N.C. Board of Pharmacy and the N.C. Division of Medical Assistance, 6/07
- Large Volume Synagis Pharmacy Distributors, 5/07
- Levitra, 11/03
- Long-Term Care Pharmacists May Seek Prescription Drug Prior Authorization, 7/02
- Lost Prescriptions Limited to One Occurrence During a 365-Day Time Period, 8/10
- Maintaining Hard Copies of Prescriptions, 6/08
- Medicaid and Health Choice Antipsychotics Programs
Pharmacy POS Override Code Protocol, 4/12
- Medicaid Recipients and Transition to
- Medical Necessity Criteria for Approval of Provigil, 11/04
- "Medically Necessary" Replaces "Dispense as Written":
- Medicare Part B Override Code Update, 3/06
- Medicare Part D Implications for North Carolina's Pharmacists and Senior Citizens:
- Medicare Part D Long Term Care Fax System, 2/06
- Medicare Part D Prescription Drug Plans, 7/05
- Medicare Part D Prescription Drug Plans and Temporary First Fill Policies, 2/06
- Medicare Part D Provider Marketing Guidelines Now Available, 10/05
- Medicaid Recipients and Transition to Medicare Part D Prescription Drug Plans, 7/05
- Medication Therapy Management Is Now Focused Risk Management (FORM), 9/07
- N.C. Medicaid and N.C. Health Choice (NCHC) Preferred Drug List Changes, 11/12
- N.C. Medicaid Preferred Drug List Changes, 6/10
- N.C. Medicaid Upper Limits for Betaseron 0.3 mg, Migranal Nasal Spray and Torado/Ketolac 10mg Tablets, 3/06
- New Appeals Process Affecting Prior Authorized Medications, 11/08
- New BIN instructions for the free ACCU-CHEK Free Meter program, 1/13
- New Pharmacy Prior Authorization Program for Second Generation Antihistamines:
- New Prior Authorization Program for Brand-name Narcotics:
- New Prior Authorization Requirements for Brand-name ACE Inhibitors, Angiotensin Receptor Blockers, and Renin Inhibitors, 9/09
- New Prior Authorization
Requirements for Brand-Name Anticonvulsants, 1/10
- New Prior Authorization Requirements for Brand-name Fibrates and Lovaza:
- New Prior Authorization Requirements for Brand-name Muscle Relaxants, 8/09
- New Prior Authorization Requirements for Brand-name Nasal Steroids, 8/09
- New Prior Authorization Requirements for Leukotriene Modifiers, 11/09
- New Prior Authorization Requirements for Serotonin 5-HT1 Receptor Agonists (Triptans), 8/09
- New Prior Authorization Requirements for Short-acting Inhaled Beta Agonists, 10/09
- New Prior Authorization Requirements for Incivek, Victrelis, Kalydeco, and Cialis, 11/12
- New Prior Authorization
Requirements for Topical Anti-inflammatory Medications, 1/10
- New Prior Authorization Requirements for Vusion
Ointment, 11/11
- New Prior Authorization Requirements for Xolair
Injection, 11/11
- New SmartPA Pharmacy Prior Authorization Program, 4/08
- Nicotine Products on the Over-the-Counter Coverage List 4/06
- Outpatient Pharmacy Program, Special Bulletin, June 2006
- Overrides for Monthly Supplies of Insulin, 11/08
- Over-The Counter Nicotine Replacement Therapy Medications Covered by Medicaid, 10/05
- Oxycontin:
- Pharmacy Audits, 6/08
- Pharmacy Dispensing Fee Changes, 1/13
- Pharmacy Episodic Drug Policy – Quantity Limitations on Sedative Hypnotics, 4/06
- Pharmacy Generic Dispensing Fee Change, 3/12
- Pharmacy Reimbursement Changes, 10/09
- Pharmacy Seminars, 4/06
- Pharmacy Stub Audits, 7/05
- Phase Two Policy Implementation, 8/11
- Plan B Product Coverage, 2/07
- Point-of-Sale Overrides for Leukotrienes, Statins, Orally Inhaled Steroids, and Second Generation Anticonvulsants
- Policies for Emend, Leukotrienes, Lidodrem, Orally Inhaled Corticosteroids, Statins, and Suboxone and Revised Policies for CII Narcotic Analgesics and Second Generation Anticonvulsants, 9/10
- Policy and Procedures for Prescribing Synagis:
- Policy Implementation: Off Label Antipsychotic Monitoring Children through Age 17, 4/11
- Prescribers not Enrolled in Medicaid, 12/12, 1/13, 2/13
- Prescribing and Documenting Brand
Medically Necessary Drugs, 6/12
- Prescription Advantage List Update, 7/05
- Prescription Limitations, 4/06
- Prescription Origin Code:
- Prior Authorization Criteria Revised for Celebrex, Procrit/Epogen and Aranesp, 4/07
- Prior Authorization for Prescription Drugs, Special Bulletin II, April 2002
- Prodigy Diabetic Supplies Under the Durable Medical Equipment and Pharmacy Programs,
- Program Integrity Monitoring of Focused Risk Management Program, 9/07
- Proton Pump Inhibitors:
- Providing Compounded Prescriptions for Medicaid Recipients, 10/05
- Recipient Lock-In to One Pharmacy Per Month, 6/03
- Recipient Management Lock-in Program Emergency Fill, 10/10
- Recipients with Medicare Deductibles, 3/06
- Recipient Opt-In Program and Monthly Prescription Limits, 2/13
- Removal of Active Pharmaceutical Ingredients and Excipients as Covered Outpatient Drugs, 12/10
- Removal of ADHD Drugs and Rebetron from the Prior Authorization Drug List, 9/04
- Removal of Cough and Cold Medications from Coverage, 12/09
- Removal of Enbrel from the Authorization Drug List, 3/05
- Removal of Impotency Drugs from Medicaid Coverage, 7/05
- Removal of Neupogen from the Prior Authorization Drug List, 4/07
- Removal of Smoking Cessation Medications and Products from the Prior Authorization Drug List, 11/04
- Reporting Changes of Address and Contact Information, 11/05
- Requesting Changes to the Pharmacy Opt-in Provider, 2/08
- Revised Criteria 1a through 1d Synagis Form, 11/04
- Revised Prior Authorization Requirements for Leukotriene Modifiers, 11/12
- Roche ACCU-CHEK Diabetic Supplies Under
the DME and Pharmacy Programs
- Senior Care Drug Assistance Program, 11/02
- Six Prescription Limit and Recipient Lock-In To One Pharmacy Each Month, 7/05
- State Maximum Allowable Cost Changes, 10/09
- Suboxone, Subutex, and Buprenorphine Prior Authorization, 1/11
- Substitution for Duoneb and Insulin Cartridges and Pens, 9/10
- Substitution of Preferred Brand Drugs, 9/10
- Suppliers of Medicare Durable Medical Equipment, 10/09
- Tacrolimus Added to the Narrow Therapeutic Index List, 6/09
- Technical Correction to General Policy for Over the Counter Medications, 9/04
- Transition Period for Oral Inhaled Corticosteroids, Leukotrienes, and Statins, 3/11
- Upcoming Policy Implementation: Off Label AntipsychoticMonitoring in Children through Age 17, 3/11
- Upcoming Policy Implementation:
March 20, 2012 Off Label Antipsychotic Safety Monitoring in Recipients 18 and
Older, 3/12
- Upcoming Policy Implementation: Off Label Antipsychotic Safety Monitoring in
NC Health Choice Recipients
- Upcoming Policy Implementation: Off Label
Antipsychotic Safety Monitoring in
Recipients 18 and Older
- Update: Active Pharmaceutical Ingredients and Excipients, 3/11
- Updated Prescription Advantage List, 6/08
- Vacation Supply Prescriptions Limited to Once a Year, 11/11
